BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3239 related articles for article (PubMed ID: 7059764)

  • 1. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients.
    Milton GW; Shaw HM; McCarthy WH; Pearson L; Balch CM; Soong SJ
    Br J Surg; 1982 Feb; 69(2):108-11. PubMed ID: 7059764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma.
    Crowley NJ; Seigler HF
    Cancer; 1990 Dec; 66(12):2522-7. PubMed ID: 2249194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive lymphadenectomy in cutaneous malignant melanomas. A matched pair study].
    Hotz G; Hagedorn M; Petres J; Wiebelt H
    Hautarzt; 1986 Oct; 37(10):554-9. PubMed ID: 3793478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
    Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
    Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.
    Reintgen DS; Cox EB; McCarty KS; Vollmer RT; Seigler HF
    Ann Surg; 1983 Sep; 198(3):379-85. PubMed ID: 6615058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanoma.
    Kretschmer L; Preusser KP; Marsch WC; Neumann C
    Melanoma Res; 2000 Oct; 10(5):483-9. PubMed ID: 11095410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for wide local excision and regional node dissection for high-risk cutaneous melanoma.
    Karakousis CP
    Curr Opin Gen Surg; 1993; ():303-9. PubMed ID: 7583999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
    Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
    Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma.
    Breslow A
    Ann Surg; 1975 Nov; 182(5):572-5. PubMed ID: 1190862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
    Veronesi U; Adamus J; Bandiera DC; Brennhovd IO; Caceres E; Cascinelli N; Claudio F; Ikonopisov RL; Javorskj VV; Kirov S; Kulakowski A; Lacoub J; Lejeune F; Mechl Z; Morabito A; Rodé I; Sergeev S; van Slooten E; Szcygiel K; Trapeznikov NN
    N Engl J Med; 1977 Sep; 297(12):627-30. PubMed ID: 895764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of regional lymph nodes in cutaneous melanoma.
    Balch CM
    J Am Acad Dermatol; 1980 Nov; 3(5):511-24. PubMed ID: 7217379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma.
    Singletary SE; Byers RM; Shallenberger R; McBride CM; Guinee VF
    Am J Surg; 1986 Oct; 152(4):371-5. PubMed ID: 3766866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma.
    Egger ME; Brown RE; Roach BA; Quillo AR; Martin RC; Scoggins CR; Stromberg AJ; McMasters KM
    J Am Coll Surg; 2014 Jul; 219(1):101-8. PubMed ID: 24726566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
    White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node dissection for primary cutaneous melanoma: a community hospital's initial experience.
    Habib FA; Lodish ME; Mittal VK; Young SC
    Am Surg; 2000 Mar; 66(3):291-5. PubMed ID: 10759202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma.
    McCarthy WH; Shaw HM; Milton GW
    Surg Gynecol Obstet; 1985 Dec; 161(6):575-80. PubMed ID: 4071371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
    Cole DJ; Baron PL
    Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 162.